Skip to main content

Fujitsu and ACRES Have Signed Alliance Agreement to Develop Integrated IT Platform for Global Clinical Research/Clinical Trial Network

Fujitsu Limited has joined the ACRES (The Alliance for Clinical Research Excellence and Safety) Strategic Alliance under a memorandum of understanding. The alliance includes cutting-edge IT vendors and global standard initiatives (CDISC, SAFE-BioPharma Association and CareLex) working together in an effort to create an integrated global platform supporting clinical research and clinical trial worldwide.

Fujitsu's participation in the Alliance strengthens the presence in healthcare information systems and life science R&D systems both in Japan and globally, meets the global standards and contributes to the development of the innovative global clinical research/trial environment.

Fujitsu and ACRES are establishing a technical working party, the ACRES-Fujitsu Technology Innovation Group, to explore closer alignment of electronic medical records (EMRs) and clinical research information systems, an essential step toward enabling innovative systems capabilities, facing market challenges in establishing remote risk-based monitoring, online electronic auditing, and real-time pharmacovigilance safety monitoring.

ACRES President and CEO, Dr. Greg Koski stated, "Emerging from the efforts of Dr. Kyoko Imamura and our colleagues at ACRES Japan, including its President, Dr Fumimaro Takaku, our partnership with Fujitsu is a landmark event. The decision of one of the world's leading technology companies to join the ACRES Alliance attests to the power of systems thinking and multi-sector collaboration. The world of medicines development is undergoing transformation, and Fujitsu is helping ACRES Allies envision and build the future."

ACRES Vice-President for Collaborative Network Development. Al Pacino said, "Fujitsu's expertise brings extraordinary resources to ACRES global technology initiatives-this is a major milestone. Successful integration of electronic health records and clinical trials information greatly furthers ACRES goal to get safe, effective medicines to the people who need them as efficiently as possible."

Head of Fujitsu's Next Generation Healthcare Innovation Center, Hirofumi Gouda, notes that "Fujitsu has high expectations that ACRES efforts and the Global Network System will not only greatly improve Quality Cost Delivery (QCD) in the related areas in clinical trials and clinical research, but also become a very important collaborative platform for helping creating a new knowledge base, including an evolving collaboration with stakeholders in healthcare and life science worldwide."


ACRES (The Alliance for Clinical Research Excellence and Safety), based in Cambridge, Massachusetts in the US, is a neutral, non-industry organization operating in the public interest, accelerating the development of safe, effective medicines and medical devices to improve the quality of life and productivity of all people world-wide.